ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Jinarc 45 mg + 15 mg, Tabletten - 28 + 28
65676006 Otsuka Pharmaceutical (Switzerland) GmbH
Jinarc 45 mg + 15 mg, Tabletten21.04.2016
  21.04.2016
Tolvaptan (C03XA01) 
WHO-DDD 
05.02.28 + 28
05.02. 
A  
Yes 
IPCI
1288.92Yes
    
10 %1418.20
7680656760065Synthetika
6671534 
Composition
A): tolvaptanum 45 mg, hydroxypropylcellulosum, lactosum monohydricum 12.629 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso. B): tolvaptanum 15 mg, hydroxypropylcellulosum, lactosum monohydricum 36.913 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso.
Packungsbestandteile
A
 
Tablets 
 
Active AgentDose
Tolvaptanum45 mg
BAG: Active AgentDose
Tolvaptanum15 mg
 
Inactive agentsDoseadditional_information
Cellulosum Microcristallinum  
E 132 color.
Hydroxypropylcellulosum  
Hydroxypropylcellulosum Substitutum Humile  
Lactose Monohydrate12.629 mg 
Magnesii Stearas  
Maydis Amylum  
Pro Compresso  
 
B
 
Tablets 
 
Active AgentDose
Tolvaptanum15 mg
BAG: Active AgentDose
Tolvaptanum15 mg
 
Inactive agentsDoseadditional_information
Cellulosum Microcristallinum  
E 132 color.
Hydroxypropylcellulosum  
Hydroxypropylcellulosum Substitutum Humile  
Lactose Monohydrate36.913 mg 
Magnesii Stearas  
Maydis Amylum  
Pro Compresso  
 
Source
Data was imported : 05.01.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home